Sol-Gel Technologies (SLGL) Operating Expenses (2017 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Operating Expenses came in at $4.0 million in Q1 2026, down 60.76% year-on-year from $10.1 million in Q1 2025, and down 4.76% on a QoQ basis from $4.2 million in Q4 2025.
Sol-Gel Technologies (SLGL) Operating Expenses (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Operating Expenses data on file, last reported at $4.0 million in Q1 2026.
- On a quarterly basis, Operating Expenses fell 60.76% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $20.8 million, a 21.27% decrease from a year earlier, with the FY2025 full-year figure at $27.0 million, up 14.56% from the prior year.
- Operating Expenses for Q1 2026 stood at $4.0 million, down from $4.2 million in the prior quarter.
- Over the last five years, Operating Expenses for SLGL reached as high as $11.4 million in Q1 2023 and fell as low as $3.8 million in Q2 2024.
- Historically, Operating Expenses has averaged $6.2 million across 5 years, with a median of $6.2 million in 2024.
- Across the five-year window, Operating Expenses soared 90.88% in 2023 and sank 60.76% in 2026, its largest moves.
- Year by year, Operating Expenses stood at $6.3 million in 2022, then dropped by 6.5% to $5.9 million in 2023, then gained by 8.18% to $6.4 million in 2024, then tumbled by 34.75% to $4.2 million in 2025, then retreated by 4.76% to $4.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $4.0 million in Q1 2026, $4.2 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Sol-Gel Technologies | 234.04 Mn | 223.91 Mn | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96 Mn |
| Dec 31, 2025 | 4.16 Mn |
| Sep 30, 2025 | 6.69 Mn |
| Jun 30, 2025 | 6.03 Mn |
| Mar 31, 2025 | 10.10 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 6.19 Mn |
| Jun 30, 2024 | 3.81 Mn |
| Mar 31, 2024 | 7.18 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 7.12 Mn |
| Mar 31, 2023 | 11.36 Mn |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 6.82 Mn |
| Sep 30, 2021 | 8.12 Mn |
| Jun 30, 2021 | 8.97 Mn |